Business Context and Reporting Period
This Form 8-K was filed by Nukkleus Inc. (trading symbol: NUKK) on August 28, 2025. The filing reports the entry into a Material Definitive Agreement involving the company, its wholly-owned Israeli subsidiary Nukk Picolo Ltd., and Mandragola Ltd. The company is an emerging growth company incorporated in Delaware.
Key Financial Metrics and Transaction Details
This filing does not report standard financial performance metrics such as revenue, profit, cash flow, or debt levels for the reporting period. Instead, it details the financial terms of a new Joint Venture (JV) agreement:
- Equity Structure: Nukk Picolo will hold a 51% equity interest in the new JV Company.
- Debt/Liquidity Support: Mandragola has committed to a 24-month credit line of up to $2 million for the JV Company.
- Compensation to Partner: Nukkleus issued Mandragola:
- 310,000 restricted shares of common stock.
- Warrants to purchase 250,000 shares at an exercise price of $4.40.
- Performance warrants to purchase 350,000 shares at an exercise price of $6.00.
Material Changes and Strategic Initiatives
The primary material change is the establishment of a joint venture in Israel aimed at creating advanced manufacturing zones in the Baltics and Israel. Key strategic components include:
- Development of a NATO-compliant logistics hub in Riga.
- Facilities for licensed maintenance, repair, and overhaul (MRO), aircraft modernization, resale, and leasing.
- Deployment of de-icing technology for commercial aircraft, recently licensed exclusively from Blade Ranger Ltd.
- Call Option: Nukkleus retains the right to require Mandragola to sell its interest in the JV Company in exchange for Nukkleus common stock based on a specified valuation.
Guidance, Risks, and Contingencies
Performance Contingency: The 350,000 performance warrants issued to Mandragola are contingent upon the JV Company achieving $25 million in cumulative revenue within a five-year period. If this target is not met, the warrants will expire.
Regulatory Status: The securities issued to Mandragola were sold in reliance on an exemption from registration under Regulation S.
Management Commentary: The filing does not provide forward-looking financial guidance or specific management commentary beyond the description of the JV's intended scope and the terms of the agreement.
Key Facts for Investor Verification
- Verify the specific valuation methodology for the potential buyout of Mandragola's JV interest.
- Confirm the operational timeline for the Riga logistics hub and Baltic manufacturing zones.
- Assess the feasibility of the $25 million revenue target required to vest the performance warrants.
- Review the attached Joint Venture Agreement (Exhibit 10.1) for detailed governance and exit clauses.
- Monitor the utilization of the $2 million credit line provided by Mandragola.